![]() |
市場調查報告書
商品編碼
1494827
穿戴式機器人和外骨骼的全球市場:分析 - 按類型、按身體部位、按技術、按應用、按最終用戶、按地區和預測(截至 2030 年)Wearable Robots and Exoskeletons Market Forecasts to 2030 - Global Analysis By Type (Passive Exoskeletons, Powered Exoskeletons and Other Types), Body Part (Lower Body, Full Body and Upper Body), Technology, Application, End User and By Geography |
預計2024年全球穿戴式機器人和外骨骼市場規模將達17.9億美元,預測期內複合年成長率為44.4%,到2030年將達到162.3億美元。
穿戴式機器人/外骨骼是旨在提高人類表現的機械設備。提供身體支持和幫助,尤其是在需要力量和耐力的任務中。透過增加佩戴者的肌肉力量和耐力,這些設備可應用於醫療保健、軍事和工業等各個領域。它們可以幫助受傷或手術後的康復,幫助工人輕鬆舉起重物,並提高士兵在戰場上的表現。
根據 Maxon Motor AG 的研究,估計全球約有 1.85 億人每天使用輪椅。帕金森氏症基金會估計,到2020年,美國帕金森氏症患者人數可能達到約93萬人,預計2030年將達到120萬人。
殘障人士數量增加和人口老化
殘障人士數量的增加和人口老化是穿戴式機器人和外骨骼市場的重要促進因素。隨著人口老化,對增強流動性和協助日常活動的解決方案的需求日益成長。穿戴式機器人/外骨骼恰好滿足了這一需求,支持有運動障礙或老齡化相關限制的個體的獨立性並提高其生活品質。這些技巧可以幫助執行原本難以執行的任務,例如行走、舉重和長時間站立。
高成本
穿戴式機器人和外骨骼市場的高成本限制是普及的重大經濟障礙。製造這些設備需要複雜的工程和先進的技術,導致生產成本高。此外,製造業有限的規模經濟導致價格更高。因此,獲得這些創新技術主要僅限於財力雄厚的產業或富人。這種成本限制阻礙了大眾市場滲透的潛力,並限制了這些設備在醫療保健、製造和國防等各個領域所能提供的好處。
不斷增加的醫療保健和復健需求
對醫療保健和復健服務的需求不斷成長正在推動穿戴式機器人和外骨骼市場的成長。這些創新技術為身體殘疾和受傷的人提供了更多的活動能力和支持,從而提高了他們的獨立性和生活品質。隨著人口老化的增加和慢性病發病率的增加,對支持日常活動和復原過程的解決方案的需求日益成長。穿戴式機器人外骨骼透過為每個用戶的特定需求提供可自訂的支援來滿足這一需求,它們在全球醫療保健機構和復健中心的採用正在迅速增加。
有限的知識和指導
穿戴式機器人和外骨骼市場中有限的知識和指導威脅是指對這些先進設備的正確使用和維護的理解和指導不足所帶來的風險。用戶可能不完全了解其功能和限制,這可能會導致誤用和事故。培訓和教育資源不足可能會進一步加劇這種風險,導致人身傷害和設備損壞。應對這項威脅需要全面的用戶教育計畫和製造商的明確說明。
穿戴式機器人/外骨骼市場受到了 COVID-19 的多方面影響。儘管疫情引起了人們對這些設備在醫療保健環境中的價值的關注,但全球供應鏈和製造業務的中斷導致生產和交貨延遲。由於疫情造成的經濟不確定性,工業和軍事應用的穿戴式機器人和外骨骼的需求也有所下降。然而,遠端醫療和遠端患者監護的日益普及預計將增加醫療保健行業對穿戴式機器人和外骨骼的需求,從而創造巨大的市場機會。
預計在預測期內工業部門將是最大的
由於穿戴式機器人/外骨骼在製造、物流和建築領域的使用不斷增加,預計在預測期內,工業領域將佔據穿戴式機器人/外骨骼的最大市場佔有率。穿戴式機器人和外骨骼被用來提高工業工作的生產力和效率,同時減少工人的疲勞和受傷風險。由於製造業對自動化和機器人技術的需求不斷增加,預計市場將繼續擴大。隨著公司尋求提高工人的生產力和安全性,穿戴式機器人和外骨骼預計將在物流和建築領域變得普及流行。
復健產業預計在預測期內複合年成長率最高
預計康復產業在預測期內將出現最快的複合年成長率。復健領域是市場上成長最快的領域。這是由於殘障人士數量不斷增加,以及對加速疾病和受傷復健的醫療設備的需求不斷增加。由於穿戴式機器人和外骨骼的出現,復健市場正在擴大。預計這一趨勢未來仍將持續。
預計在預測期內,北美將佔據全球穿戴式機器人和外骨骼市場的最大佔有率。這是由於對能夠改善患者治療結果和工人安全的設備的需求不斷增加,而醫療保健和工業部門是北美成長的主要驅動力。此外,北美市場的成長也受到該領域重要製造商的存在和技術進步的推動。
在亞太地區,由於工業和醫療保健領域擴大使用這些設備,預計穿戴式機器人和外骨骼市場的複合年成長率最高。隨著人口持續老化和殘障人士比例較高,亞太地區市場預計將擴大。廉價勞動力的可用性和政府鼓勵採用最尖端科技的支持措施預計也將刺激該地區的市場擴張。
According to Stratistics MRC, the Global Wearable Robots And Exoskeletons Market is accounted for $1.79 billion in 2024 and is expected to reach $16.23 billion by 2030 growing at a CAGR of 44.4% during the forecast period. Wearable robots and exoskeletons are mechanical devices designed to enhance human capabilities. They provide physical support and assistance, particularly in tasks requiring strength or endurance. By augmenting the wearer's strength and endurance, these devices find applications in various fields, including healthcare, military, and industry. They can aid in rehabilitation after injury or surgery, enable workers to lift heavy objects with ease, and enhance soldiers' performance on the battlefield.
According to a study by Maxon Motor AG, the company estimated that approximately 185 million people use a wheelchair daily worldwide. According to the Parkinson's Foundation estimates, the number of people in the United States with Parkinson's disease may be around 930,000 in 2020, and it is expected to reach 1,200,000 by 2030.
Increasing prevalence of disabilities and an aging population
The increasing prevalence of disabilities and an aging population are significant drivers in the wearable robots and exoskeletons market. As populations age, there's a growing need for solutions that enhance mobility and provide assistance in daily activities. Wearable robots and exoskeletons offer precisely that, aiding individuals with mobility impairments or age-related limitations to maintain independence and improve quality of life. These technologies enable users to perform tasks they might otherwise struggle with, such as walking, lifting, or standing for extended periods of time.
High cost
High cost restraint in the wearable robots and exoskeletons market is the significant financial barrier hindering widespread adoption. The intricate engineering and advanced technology involved in creating these devices contribute to their high production costs. Additionally, limited economies of scale in manufacturing further inflate prices. As a result, accessibility to these transformative technologies is restricted, primarily to well-funded industries or affluent individuals. This cost constraint impedes the potential for mass-market penetration and limits the benefits these devices could offer in various fields, including healthcare, manufacturing, and defense.
Increase in the need for healthcare and rehabilitation
The rise in demand for healthcare and rehabilitation services has propelled the growth of the wearable robots and exoskeletons market. These innovative technologies offer enhanced mobility and support for individuals with physical impairments or injuries, thereby increasing their independence and quality of life. As the aging population grows and the incidence of chronic conditions rises, there's a heightened need for solutions that can assist in daily activities and rehabilitation processes. Wearable robots and exoskeletons cater to this demand by providing customizable support tailored to each user's specific needs, leading to a surge in their adoption across healthcare facilities and rehabilitation centers globally. This
Limited knowledge and instruction
The threat of limited knowledge and instruction in the wearable robots and exoskeletons market refers to the risk posed by inadequate understanding or guidance regarding the proper usage and maintenance of these advanced devices. Users may not fully comprehend their capabilities or limitations, leading to misuse or accidents. Insufficient training and educational resources further exacerbate this risk, potentially resulting in injuries or damage to the equipment. Addressing this threat requires comprehensive user education programs and clear instructions provided by manufacturers.
The Wearable robot and exoskeleton Market has been impacted by COVID-19 in a variety of ways. Even though the pandemic has brought attention to the value of these devices in healthcare settings, delays in production and delivery have resulted from the disruption of global supply chains and manufacturing operations. The demand for wearable robots and exoskeletons in industrial and military applications has also decreased as a result of the economic uncertainty brought on by the pandemic. However, it is anticipated that the growing use of telemedicine and remote patient monitoring will fuel demand for wearable robots and exoskeletons in the healthcare industry, creating a sizable opportunity for the market.
The industrial segment is expected to be the largest during the forecast period
The industrial sector will hold the largest market share for wearable robots and exoskeletons during the forecast period as a result of the growing use of these tools in the manufacturing, logistics, and construction sectors. Wearable robots and exoskeletons have been used to increase the productivity and efficiency of industrial operations while lowering worker fatigue and injury risks. Due to the growing demand for automation and robotics in the manufacturing sector, the market is anticipated to continue expanding. As businesses look to increase worker productivity and safety, wearable robots and exoskeletons are also anticipated to become more common in the logistics and construction sectors.
The rehabilitation segment is expected to have the highest CAGR during the forecast period
The rehabilitation segment is anticipated to witness the fastest CAGR growth during the forecast period. The rehabilitation sector has experienced some of the fastest growth in the market. This is brought on by an increase in both the prevalence of disabilities and the demand for medical equipment that can speed up patients' recoveries from illnesses and injuries. The rehabilitation market is expanding as a result of the availability of wearable robots and exoskeletons that can offer patients with mobility impairments the much-needed assistance they require. In the years to come, this trend is anticipated to persist.
During the forecast period, North America is anticipated to account for the largest share of the global market for wearable robots and exoskeletons, due to the rising demand for devices that can enhance patient outcomes and worker safety, the healthcare and industrial sectors have been the main drivers of growth in North America. Moreover, the growth of the market in North America has also been aided by the presence of significant manufacturers and technological advancements in the area.
Due to the growing use of these devices in the industrial and healthcare sectors in the region, Asia-Pacific is predicted to have the market for wearable robots and exoskeletons with the highest CAGR. The Asia-Pacific market is anticipated to expand as a result of the region's aging population and high prevalence of disabilities. The availability of inexpensive labor and supportive government initiatives to encourage the adoption of cutting-edge technologies are also anticipated to fuel market expansion in the area.
Key players in the market
Some of the key players in Wearable Robots And Exoskeletons market include ATOUN Inc, Bionik Laboratories Corp., B-Temia Inc., Cyberdyne Inc, Daiya Industry Co., Ltd., Ekso Bionics Holdings, Inc., Focal Meditech BV, Honda Motor Co. Ltd, Lockheed Martin Corporation, Mitsubishi Heavy Industries, Ltd., Myomo Inc., P&S Mechanics Co. Ltd., Parker Hannifin Corporation, ReWalk Robotics Ltd., Rex Bionics Pty Ltd., Sarcos Corporation, Technaid S and Wearable Robotics Srl.
In May 2024, Japanese automaker Honda Motor Co said its subsidiary Honda R&D (India) Pvt Ltd has opened a new Solution R&D center in Bengaluru, Karnataka. Honda R&D (India) is the research and development arm for Honda's motorcycles and power products in India. The new R&D Center will incorporate advanced mobility technologies into electric vehicle development more quickly. It will also work on software and connected services through 'co-creating' open innovation by adopting technologies and ideas of R&D companies.
In March 2024, Sarcos Technology and Robotics Corporation ("Sarcos") (NASDAQ: STRC and STRCW) is pleased to announce that effective today, the company has changed its name to Palladyne AI Corp. (Palladyne AI). Effective April 8, 2024, the Company's ticker symbol will change from NASDAQ: STRC to NASDAQ: PDYN. The new name reflects the company's narrowed focus on commercializing the artificial intelligence and machine learning software that it has been developing since 2020.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.